Session 1096: Cancer risk evaluation

Date: 4 February 2004, Time: 14:00 - 16:00
Location: Room 2

Oral Presentations

Time	Number	Title / Authors / Affiliations
14:00	217	Biomarkers of cancer risk and prevention strategies in human populations S Bonassi PhD Department of Etiology and Epidemiology, Istituto Nazionale per la Ricerca sul Cancro, Largo R. Benzi, 10. Genoa, 16132 Italy
14:20	218	An intraductal approach for breast cancer risk assessment JY Rao MD, W Zhang MD, BN Zhang MD, QJ Pan MD, J Wu MD, K Duvall MD, MN Brooks MD David Geffin School of Medicine, UCLA, Los Angles, CA Cancer Institute/Hospital, Chinese Academy of Medical Sciences, Beijing, P. R. China
14:35	219	Multi-Stage Models of U.S. Cancer Mortality Cohort Trends KG Manton PhD^a, JS Kravchenko PhD^a, G Lowrimore PhD^a Center for Demographic Studies, Duke University, Durham, NC, United States
14:50	220	Developing Cancer Control Model – Experience of 20 Years PB Patel MS^a, SP Patel MSc^b, SP Patel BSc^a, KP Patel^a, LP Patel^a ^aSuper specialty Clinics, Shiv Shraddha Nursing Home Shahibaug, Ahmedabad 380004, India, ^bN.V. Patel college of Pure and Applied Science, S. P. University, Vallabh Vidyanager, Gujarat State, India
15:05	221	Integration of novel clinical and molecular markers into risk assessment strategies for oral premalignant lesions (OPLs): early results of a longitudinal study MP Rosin, PhD*; M Williams, DMD; C MacAulay, PhD; W Lam, PhD; L Zhang, DDS, PhD, FRCD British Columbia Cancer Agency, Vancouver, BC, Canada
15:20	222	Diagnostic value of nuclear magnetic resonance (proton NMR) and its implications on aetio-pathogenesis in human breast tissue A Srivastava, MS* (a); S Kumar, MS, FRCS, PhD, MMSc (a); R Roy, PhD (b); R Grover, PhD (b) ^aKing George's Medical College, Lucknow, India, ^bCentral Drug Research Institute, Lucknow, India
15:35	223	Biomarkers of breast cancer risk in metabolic syndrome A-S Furberg MD^a, MB Veierød PhD^b, T Wilsgaard PhD^a, L Bernstein PhD^c, MD Thune PhD^a,d ^aFaculty of Medicine, Institute of Community Medicine, University of Tromsø, Tromsø, Norway, ^bSection of Medical Statistics, University of Oslo, Oslo, Norway, ^cKeck School of Medicine, University of Southern California, Los Angeles, CA, United States, ^dUllevål University Hospital, Oslo, Norway

Poster Presentations

Number	Title / Authors / Affiliations
208	Age-Standardized Cancer Ratio (ASCAR) for cancer of bladder in Fars Province, Southeastern Iran, 2001-2002 D Mehrabani PhD^a, SZ Tabei PhD^b, MR Panjehshahin PhD^b, SJ Shamsnia MSc^b ^aRazi Vaccine and Serum Research Institute, Shiraz University, Shiraz, Iran, ^bShiraz University of Medical Sciences, Shiraz, Iran
209	Age-Standardized cancer ratio (ASCAR) for leukemia in Fars Province, Southeastern Iran, 2001-2002. SZ Tabei PhD^a, MR Panjehshahin PhD^a, SJ Shamsnia MSc^a, D Mehrabani PhD^b ^aShiraz University of Medical Sciences, Shiraz, Iran, ^bRazi Vaccine & Serum Research Institute, Shiraz University, Shiraz, Iran
210	Age-standard cancer ratio (ASCAR) for breast cancer in Fars Province, Southern Iran, 2001-2002 SJ Shamsnia MSc^a, SZ Tabei PhD^a, MR Panjeshahin PhD^a, D Mehrabani PhD^b (a)Shiraz University of Medical Sciences, (b)Razi Vaccine & Serum Research Institute, Shiraz university, Shiraz Iran
224	Evaluation of cancer risk in small communities: results of two approaches E Kordysh MD PhD^a, A Bolotin PhD^a, M Barchana MD PhD^b, R Chen PhD^c ^aDepartment of Epidemiology, Ben- Gurion University, Beersheba, Israel, ^bIsrael Cancer Registry, Jerusalem, Israel, ^cImpulse Dynamics, Haifa, Israel
225	Geographic distribution of cancer at micro-scale in the southern part of Quebec, Canada JF Emard, J Martinez, JP Thouez Centre de recherche, Centre hospitalier de l’Université de Montréal (CHUM) - Hôtel-Dieu, 3850, St-Urbain, Montréal (Qc) Canada H2W 1T7
226	Mortality and changing epidemiological trends in Iran during 1979-2001 with emphasis on cancer P Yavari PhD, A Abadi MSc, Y Mehrabi PhD Social Medicine Department, School of Medicine, Shahid Beheshti university, Tehran, Iran
227	Intention to quit tobacco in northern India V Dwivedi, MA*; S Kumar, MS, FRCS, PhD, MMSc; S Vasandani, MA; K Singh, MSc Department of Surgery and Clinical Epidemiology, King George's Medical University, Lucknow, India
228	Polymorphisms of the methylenetetrahydrofolate reductase in squamous intraepithelial lesion and cervical cancer in women of southern Mexico MS Antonio-Véjar^a, B Illades-Aguiar PhD^a, E Flores-Alfaro MS^a, MA Leyva-Vázquez PhD^a, S López-Silva PhD^b, MA Terán-Porcayo MD^c (a) Laboratorio de Biomedicina Molecular, Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Guerrero, Chilpancingo, Guerrero, México. (b) Facultad de Medicina, Universidad Autónoma de Guerrero, Acapulco, Guerrero, México. (c) Instituto Estatal de Cancerología “Dr. Arturo Beltrán Ortega”, Acapulco, Guerrero, México.
229	Helicobacter pylori and gastric cancer in Chile G Figueroa, M Troncoso, GR Faúndez, PC Rivas Microbiology Laboratory, Institute of Nutrition and Food Technology, University of Chile, Santiago, Chile
230	Perception of risk and surveillance practices for women with a family history of breast cancer WL Martin RN BSN Faculty of Nursing, University of Manitoba, Winnipeg, Canada
231	Breast cancer in Brasil: Trends in survival rates UA Gomes PhD^a, SJ Adad MD^a, EC Mauad MD^b, AL Rodrigues PhD^a ^aFaculty of Medicine of Ribeirão Preto – University of São Paulo, State of São Paulo, Brazil, ^bCancer Hospital of Barretos – Pio XII Foundation, State of São Paulo, Brazil
232	The relationship between endometrial carcinoma and coexistent adenomyosis uteri, endometriosis externa and myoma uteri M Koshiyama MD, K Yamamoto MD, T Okamoto MD, M Ueta MD Department of Obstetrics and Gynecology, Himeji National Hospital, Himeji, Hyogo, Japan
233	Gene expression as biomarker of early carcinogenesis I Ember; I Kiss; Z Gyöngyi; C Varga Department of Public Health, Medical Faculty, Pécs University of Sciences
234	An approach to the relevance between varations in hormone secretion and the incidence of Hyperplasia of Mammary Glands and Mammary Cancer C Chen BSc^a, Y Lin MD^b (a)Physician director Oncology department of Xiamen First Hospital,Fujian province,PR China; (b)Xiamen First Hospital, Fujian province, PR China
235	Biomonitoring of pathology and anatomy workers using genotoxic assays T Orsière PhD, MD Sari-Minodier PhD, L Bellon, J Pompili, A Botta MD PhD Laboratoire de Biogenotoxicologie et Mutagenese Environnementale, Faculté de Medecine, Universite de la Méditerranee, Marseille, France
236	Evaluation of comet assay responses in exfoliated cells compared to voided urine cytology ME Fracasso MPH^a, P Franceschetti PhD^a, G Talamini MD^b, F Bonetti MD^c, D Doria^a ^a* Department of Medicine and Public Health, Section of Pharmacology, ^bDepartment of Biochemical Science and Surgery, ^cDepartment of Pathology; University of Verona, Policlinico Borgo Roma, Verona, Italy
237	Treatment of huge uterine tumors thought to be benign in post-menopausal woman T Okamoto MD, M Koshiyama MD, K Yamamoto MD Department of Obstetrics and Gynecology, Himeji National Hospital, Himeji, Hyogo, Japan
238	Tobacco habit in northern India V Dwivedi, MA*; S Kumar, MS, FRCS, PhD, MMSc; S Vasandani, MA; K Singh, MSc Departments of Surgery and Clinical Epidemiology UnitKing George's Medical University, Lucknow, India
239	Cancer contribution in smoking-related effects on white U.S. population: analysis of interventions using microsimulation approach. PhD Akushevich, J Kravchenko MD PhD, KG Manton PhD Center for Demographic Studies, Duke University, Durham, NC, United States
240	Study of DNA damage with comet electrophoresis in oral mucosal cells of patient with oral squamous cell carcinoma PB Patel MS^a, SP Patel MSc^b, SP Patel BSc^a, KP Patel^a, LP Patel^a ^aSuper Specialty Clinics, Shiv Shraddha Nursing Home Shahibaug, Ahmedabad 380004, Chennai, ^bShree Ramchandra Medical College and Research Insitute, Porur, Chennai, India
241	Reliability of a smoking cessation risk factor interview scale (SCRFIS) for use with standardized patient instructors KL Foley PhD^a, SJ Crandall PhD^b, G George MPH^b, MR Roman MPH^a, JG Spangler MD MPH^b ^aDepartment of Public Health Sciences, ^bDepartment of Family and Community Medicine Wake Forest University School of Medicine, Winston-Salem, NC, United States
320	Interleukin 10 promoter region polymorphism and Epstein Barr virus associated lymphomas CYS Li MSc^a, JKM Ko BSc^a, KIK Lei^b, BM Whitney PhD^b, WY Chan MD^a (a)Department of Anatomical & Cellular Pathology, The Chinese University of Hong Kong. (b) Clinical Oncology Unit, Prince of Wales Hospital, Hong Kong.
321	The effectiveness of teaching in knowledge and life style of urban and rural women in relation to breast cancer in Shiraz, Southern Iran. L Malekjamshidi BSc^a, D Mehrabani PhD^b, R Tavana BSc^a ^aShiraz University of Medical Sciences, Shiraz, Iran, ^bRazi Vaccine & Serum Research Institute, Shiraz University, Shiraz, Iran
322	The effect of colorectal cancer stage on hospital-based costs DAL Macafee*, MRCS (a); JH Scholefield, FRCS (a); DK Whynes, BA, BPh(b) ^aDivision of GI Surgery, Queens Medical Centre, Nottingham, United Kingdom, ^bDepartment of Economics, University of Nottingham, Nottingham, United Kingdom
323	Providing Information About Breast Cancer Via Public Forums PB Patel MS^a, SP Patel BSc^b, S-P Patel BSc^a, KP Patel^a, LP Patel^a ^aSuper specialty Clinics, Shiv Shraddha Nursing Home Shahibaug, Ahmedabad 380004, Chennai, ^bShree Ramchandra Medical College and Research Indtitute, Porur, Chennai, India
324	A qualitative study of the acceptability of reflex HPV testing as a cervical screening option P Ritvo PhD^a,b,c,f,g, R Howlett MA, B Sc MA^a,c,g, M Cotterchio PhD^a,b, A Matthew MA^c, B Rosen MD^d,e, J Murphy MD^d,e, MD Mai^a,b ^aDivision of Preventive Oncology, Cancer Care Ontario, Toronto, Ontario, Canada, ^bDepartment of Public Health Sciences, ^eDivision of Obstetrics and Gynecology; University of Toronto, Toronto, Ontario, Canada, ^cDivision of Epidemiology, Biostatistics and Behavioural Science, Ontario Cancer Institute, University Health Network, Toronto, Ontario, Canada, ^dDepartment of Gynecology Oncology, University Health Network, Toronto, Ontario, Canada, ^fSchool of Kinesiology and Health Sciences, ^gDepartment of Psychology; York University, Toronto, Ontario, Canada
325	Comparison of PAP test rates across Ontario and factors associated with cervical screening participation G Fehringer, MSc (a); R Howlett, MASc (a)*; M Cotterchio, PhD (a,b); V Majpruz, MSc (a); N Klar, PhD (a,b); V Mai, MD (a) ^aDivision of Preventive Oncology, Cancer Care Ontario, Toronto, ON, Canada, ^bDepartment of Public Health Sciences, Faculty of Medicine, University of Toronto, Toronto, ON, Canada